Navigation Links
Hope on the horizon for asthma sufferers
Date:9/17/2012

A new study that identifies ways to reduce the factors that lead to an asthma attack gives hope to asthma sufferers. A UCSF researcher and his colleagues believe they have found a way to help asthma sufferers by impeding the two most significant biological responses that lead to an asthma attack.

Asthma, a respiratory disorder that causes shortness of breath, coughing and chest discomfort, results from changes in the airways that lead to the lungs. It affects 18.7 million adults and 7.0 million children in the US, according to the Centers for Disease Control and Prevention.

In a paper published Monday in the Proceedings of the National Academy of Sciences (PNAS), researchers from UCSF, Johns Hopkins University and Duke University demonstrate that a specific calcium-activated chloride channel holds valuable clues to reducing two biological processes that contribute to the severity of asthma. These channels regulate airway secretions and smooth muscle contraction, the two major factors that lead to an asthma attack.

"Maybe if we could inhibit both of these processes by blocking this one channel, then we could affect the two symptoms of asthma," said senior author Jason Rock, PhD, assistant professor at the UCSF Department of Anatomy.

Normally humans have few mucus-producing cells but asthma sufferers have an elevated number of these cells in the lining of the tubes that lead to the lungs. Asthmatics also have an abnormal amount of smooth muscle surrounding the airway tubes. Even the slightest stimulus can cause these to contract.

"The overabundance of mucus plugging the airways combined with hyper-contractility of the smooth muscle when the tubes get really small make it difficult to move air in or out," Rock said. "A lot of people equate that with breathing through a straw."

Rock and his colleagues focused on a calcium-activated chloride channel called TMEM16A. This channel secretes chloride ions in response to rises in intracellular calcium. It regulates a significant number of biological processes such as neuron firing, gastrointestinal activity and the secretion of sweat and tears.

The researchers wanted to prove that the channel was present in asthma. They studied human lung samples and looked for the mRNA (messenger RNA which carries information from the DNA to the sites of protein synthesis), and compared protein levels in asthmatic and non-asthmatic patients.

"We found that the level of this channel was increased in the mucus producing cells of asthmatics compared to non-asthmatics," Rock said. "And we also validated this in several models of asthma, including mouse models. That was step one."

Step two consisted of a screen to identify chemicals that inhibit the activity of TMEM16A. The authors identified three chemicals that inhibit the channel.

"We tested the ability of these chemicals to inhibit TMEM16A and other channels, and we found that they specifically block TMEM16A," Rock said. "It is great that we came across these molecules that were unknown previously since we can now try to get into clinical trials to benefit patients."

Then, the authors simulated asthma in a dish and blocked the channel to observe whether it affected mucus production. "Mucus produced by these cells wasn't secreted as efficiently," Rock said. "We also studied airway smooth muscles of human patients who had given their organs to science, and we could see that blocking TMEM16A inhibited their contraction response as well."

Rock is in the pre-clinical phase to test the safety and effectiveness of the blockers in animal studies. If that goes well, Phase One of clinical trials can begin.

"At present, I am optimistic," Rock said. "This could be a major advance to help asthma sufferers."


'/>"/>

Contact: Leland Kim
leland.kim@ucsf.edu
415-502-6397
University of California - San Francisco
Source:Eurekalert  

Related biology news :

1. At least 200,000 tons of oil and gas from Deepwater Horizon spill consumed by gulf bacteria
2. The largest research expedition of its kind near the site of Deepwater Horizon incident
3. BP Deepwater Horizon oil spill exacerbated existing environmental problems in Louisiana marshes
4. Waves of Berkeley Lab responders deploy omics to track Deepwater Horizon cleanup microbes
5. Trouble on the horizon for GM crops?
6. Westpak Deploys Horizontal Impact Test System (HITS)
7. Microbial communities shifted dramatically after Deepwater Horizon spill
8. Study by Haverford College professor reveals unprecedented impact of Deepwater Horizon on deep ocean
9. Study confirms oil from Deepwater Horizon disaster entered food chain in the Gulf of Mexico
10. Infants exposed to specific molds have higher asthma risk
11. Leading childhood asthma group supports federal asthma action plan to reduce disparities
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Hope on the horizon for asthma sufferers
(Date:6/20/2016)... DALLAS , June 20, 2016 ... criminal justice technology solutions for public safety, investigation, ... by the prisons involved, it has secured the ... Corrections (DOC) facilities for Managed Access Systems (MAS) ... (4) additional facilities to be installed by October, ...
(Date:6/7/2016)... -- Syngrafii Inc. and San Antonio Credit Union (SACU) ... Syngrafii,s patented LongPen™ eSignature "Wet" solution into SACU,s ... in greater convenience for SACU members and operational ... document workflow and compliance requirements. Logo ... Highlights: ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces ... Clean Technology Fund I, LP and Clean Technology Fund ... venture capital funds which together hold approximately 59% of ... as converted basis), that they have entered into an ... in Biorem to TUS Holdings Co. Ltd. ("TUS") (en.tusholdings.com) ...
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)...  Liquid Biotech USA , ... Sponsored Research Agreement with The University of Pennsylvania ... cancer patients.  The funding will be used to ... clinical outcomes in cancer patients undergoing a variety ... employed to support the design of a therapeutic, ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
Breaking Biology Technology: